AlphaQuest’s 10x Genomics TXG Stock Holding History

AlphaQuest’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-41,159	Closed	-$671K	–	1947
2025 Q4	$671K	Sell	41,159 -92,260	-69%	-$1.39M	0.04%	627
2025 Q3	$1.56M	Buy	133,419 +93,514	+234%	+$1.22M	0.1%	266
2025 Q2	$462K	Buy	39,905 +10,446	+35%	+$95.2K	0.05%	634
2025 Q1	$257K	Buy	29,459 +2,258	+8%	+$28.5K	0.03%	862
2024 Q4	$391K	Buy	27,201 +13,608	+100%	+$215K	0.05%	593
2024 Q3	$307K	Sell	13,593 -3,421	-20%	-$70.7K	0.03%	892
2024 Q2	$331K	Sell	17,014 -940	-5%	-$24.6K	0.04%	604
2024 Q1	$674K	Buy	+17,954	New	+$789K	0.12%	295

Other funds holding TXG

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

QCM

Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AlphaQuest's TXG Position: Q1 2026 in Review

AlphaQuest sold out of 10x Genomics (TXG) in Q1 2026, closing a stake of 41,159 shares — an estimated $671K sold.

AlphaQuest first reported a position in TXG in Q1 2024 and held it in 8 quarters. The position peaked at $1.56M in Q3 2025. 330 funds tracked by Wall St. Rank hold TXG as of Q1 2026.

AlphaQuest reported no remaining 10x Genomics position as of Q1 2026 after selling out during the quarter.
AlphaQuest sold 41,159 10x Genomics shares in Q1 2026, an estimated $671K.
AlphaQuest first reported a position in 10x Genomics in Q1 2024 and held it in 8 quarters.
AlphaQuest's 10x Genomics position peaked at $1.56M in Q3 2025.
330 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.